The survival analysis of AGAP2-AS1 in 33 BLCA samples illustrated that the overexpression of AGAP2-AS1 was closely associated with the probability of BLCA recrudescency (p < 0.05) [46]. This evidence concerns the gene AGAP2 and bladder transitional cell carcinoma.